Cognitive Deficiency in Cannabis Consumers
Abstract
Keywords
DOI: 10.22146/buletinpsikologi.59576
References
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987). Cannabis and Schizophrenia: A Longitudinal Study of Swedish Conscripts. The Lancet, 330(8574), 1483-1486.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002). Cannabis Use in Adolescence and Risk for Adult Psychosis: Longitudinal Perspective Study. British Medical Journal, 325(7374), 1212-1213.
Atakan, Z., Bhattacharyya, S., Allen, P., Martín-Santos, R., Crippa, J. A., Borgwardt, S. J., . . . McGuire, P. (2013). Cannabis Affects People Differently: Inter-Subject Variation in the Psychotogenic Effects of Δ9-Tetrahydrocannabinol: a Functional Magnetic Resonance Imaging Study with Healthy Volunteers. Psychological Medicine, 43(6), 1255-1267.
Balhara, Y. P., & Jain, R. (2014). Cannabis Use Among Opioid-Dependent Individuals on Opioid Substitution Therapy. Journal of Pharmacology and Pharmacotherapeutics, 5(3), 203-205.
Bassavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S. (2017). Endocannabinoid System in Neurodegenerative Disorders. Journal of Neurochemistry, 142(5), 624-648.
Bhattacharyya, S., Fusar-Poli, P., Borgwardt, S., Martin-Santos, R., Nosarti, C., O’Carroll, C., . . . McGuire, P. (2009). Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol: A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis. Archives of General Psyciatry, 66(4), 442-451.
Blakemore, S. -J. (2008). The Social Brain in Adolescence. Nature Reviews Neuroscience, 9(4), 267-277.
Blakemore, S. -J., & Choudhury, S. (2006). Development of the Adolescent Brain: Implications for Executive Function and Social Cognition. Journal of Child Psychology and Psychiatry, 47(3-4), 296-312.
Borgwardt, S. J., Allen, P., Bhattacharyya, S., Fusar-Poli, P., Crippa, J. A., Seal, M. L., . . . McGuire, P. K. (2008). Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition. Biological Psychiatry, 64(11), 966-973.
Bossong, M. G., Jager, G., van Hell, H. H., Zuurman, L., Jansma, J. M., Mehta, M. A., . . . Ramsey, N. F. (2012a). Effects of Δ9-Tetrahydrocannabinol Administration on Human Encoding and Recall Memory Function: A Pharmacological fMRI Study. Journal of Cognitive Neuroscience, 24(3), 588-599.
Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Kahn, R. S., & Ramsey, N. F. (2013b). Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function. PloS ONE, 8(7), e70074.
Bossong, M. G., Jansma, J. M., van Hell, H. H., Jager, G., Oudman, E., Saliasi, E., . . . Ramsey, N. F. (2012b). Effects of Δ9-Tetrahydrocannabinol on Human Working Memory Function. Biological Psychiatry, 71(8), 693-699.
Bossong, M. G., van Hell, H. H., Jager, G., Kahn, R. S., Ramsey, N. F., & Jasma, M. (2013a). The Endocannabinoid System and Emotional Processing: A Pharmacological fMRI Study with Δ9-Tetrahydrocannabinol. European Neuropsychopharmacology, 23(12), 1687-1697.
Bush, G., & Shin, L. (2006). The Multi-Source Interference Task: an fMRI Task that Reliably Activates the Cingulo-Frontal-Parietal Cognitive/Attention Network. Nature Protocols, 1(1), 308-313.
Carter, R., Aldridge, S., Page, M., & Parker, S. (2019). The Human Brain Book (3rd ed.). NY, USA: DK Publishing.
Cassano, T., Calcagnini, S., Pace, L., De Marco, F., Romano, A., & Gaetani, S. (2017). Cannabinoid Receptor 2 Signalling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target. Frontiers in Neuroscience, 11, 30. doi:doi: 10.3389/fnins.2017.00030
Deutsch, D. G., & Chin, S. A. (1993). Enzymatic Synthesis and Degradation of Anandamide, A Cannabinoid Receptor Agonist. Biochemical Pharmacology, 46(5), 791-796. doi:https://doi.org/10.1016/0006-2952(93)90486-G
Diamond, A. (2013). Executive Functions. Annual Review of Psychology, 64, 135-168. doi:doi:10.1146/annurev-psych-113011-143750
Emmet, D., & Nice, G. (2009). What You Need to Know About Cannabis: Understanding the Facts. London, UK: Jessica Kingsley Publishers.
Evren, C. (2017). Cannabis Use and Cognitive Function. In V. R. Preedy, Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (pp. 70-78). London, UK: Academic Press.
Fernández-Ruiz, J., Gómez-Ruiz, M., García, G., Hernández, M., & Ramos, J. A. (2017). Modelling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies. Methods in Enzymology, 593, 175-198. doi:http://dx.doi.org/10.1016/bs.mie.2017.06.021
Fernández-Ruiz, J., Romero, J., & Ramos, J. A. (2015). Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others. In R. G. Pertwee, Endocannabinoids (pp. 233-259). Cham, Switzerland: Springer International Publishing Switzerland.
Gibbs, S. E., & D'Esposito, M. (2005). Individual Capacity Differences Predict Working Memory Performance and Prefrontal Activity Following Dopamine Receptor Stimulation. Cognitive, Affective, & Behavioral Neuroscience, 5(2), 212-221.
Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-Acute (Residual) Neurocognitive Effects of Cannabis Use: A Meta-Analytic Study. Journal of the International Neuropsychological Society, 9(5), 679-689.
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Gonenc, A., Smith, R. T., Lambros, A. M., . . . Lukas, S. E. (2018). The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment. Frontiers in Pharmacology, 8, 983.
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M. T., Smith, R. T., & Lukas, S. E. (2016). Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function. Frontiers in Pharmacology, 7, 355.
Holgado, M. A., Martín-Banderas, L., Álvarez-Fuentes, J., & Fernández-Arévalo, M. (2017). Neuroprotective Effect of Cannabinoids Nanoplatforms in Neurodegenerative Diseases. Journal of Drug Delivery Science and Technology, 42, 84-93.
Iseger, T. A., & Bossong, M. G. (2015). A Systematic Review of the Antipsychotic Properties of Cannabidiol in Humans. Schizophrenia Research, 162(1-3), 153-161.
Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., . . . Arinami, T. (2010). Brain Cannabinoid CB2 Receptor in Schizophrenia. Biological Psychiatry, 67(10), 974-982.
Kloft, L. (2017). The Efficacy of Cannabidiol (CBD) as Potential Antipsychotic Medication. Maastricht Student Journal of Psychology and Neuroscience, 6(1), 1-15.
Konrad, K., Firk, C., & Uhlhaas, P. J. (2013). Brain Development During Adolescence: Neuroscientific Insights Into This Development Period. Deutsches Ärzteblatt International, 110(25), 425-431.
Lau, T., & Schloss, P. (2008). The Cannabinoid CB1 Receptor is Expressed on Serotonergic and Dopaminergic Neurons. European Journal of Pharmacology, 578(2-3), 137-141.
Leweke, F. M., Piomelli, D., Pahlisch, F., Muhl, D., Gerth, C. W., Hoyer, C., . . . Koethe, D. (2012). Cannabidiol Enhances Anadamide Signaling and Alleviates Symptoms of Schizophrenia. Translational Psychiatry, 2(3), e94.
LGN. (2014). Sekarang Aku, Besok Kamu!: Panduan Hukum Bagi Warga Negara Pengguna Ganja (1 ed.). Tangerang Selatan, Indonesia: LGN.
Mai, L. L., Owl, M. Y., & Kersting, M. P. (2005). The Cambridge Dictionary of Human Biology and Evolution. Cambridge, UK: Cambridge University Press.
Marsicano, G., & Lafenêtre, P. (2009). Roles of the Endocannabinoid System in Learning Memory. In D. Kendall, & S. Alexander, Behavioral Neurobiology of the Endocannabinoid System (pp. 201-230). Berlin, Germany: Springer-Verlag Berlin Heidelberg.
Mateos-Aparicio, P., & Rodriguez-Moreno, A. (2019). The Impact of Studying Brain Plasticity. Frontiers in Cellular Neuroscience, 13, 66. doi:doi: 10.3389/fncel.2019.00066
Mizrahi, R., Watts, J. J., & Tseng, K. Y. (2017). Mechanisms Contributing to Cognitive Deficits in Cannabis Users. Neuropharmacology, 124, 84-88.
Mostofsky, S. H., & Simmonds, D. J. (2008). Response Inhibition and Response Selection: Two Sides of the Same Coin. Journal of Cognitive Neuroscience, 20(5), 751-761.
Oomen, P. P., van Hell, H. H., & Bossong, M. G. (2018). The Acute Effects of Cannabis on Human Executive Function. Behavioural Pharmacology, 29(7), 606-616.
Osborne, A. L., Solowij, N., & Weston-Green, K. (2017). A Systematic Review of the Effect of Cannabidiol on Cognitive Function: Relevance to Schizophrenia. Neuroscience & Biobehavioral Reviews, 72, 310-324.
Peres, F. F., Almeida, V., & Abilio, V. C. (2017). Cannabidiol: An Overview of Its Antipsychotic Properties. In V. R. Preedy, Handbook of Cannabis and Related Pathologies (pp. 787-794). London, UK: Academic Press.
Piechatzek, M., Indlekofer, F., Daamen, M., Blasmacher, C., Lieb, R., Pfister, H., . . . Schütz, C. G. (2009). Is Moderate Substance Use Associated with Altered Executive Functioning in a Population-Based Sample of Young Adults. Human Psychopharmacology Clinical and Experimental, 24, 650-665.
Pinel, J. P. (2009). Biopsikologi (7th ed.). (H. P. Soetjipto, & S. M. Soetjipto, Trans.) Yogyakarta, Indonesia: Pustaka Pelajar.
PUSLITDATIN BNN RI & PUSLITKES UI. (2017). Survey Nasional Penyalahguna NARKOBA di 34 Provinsi Tahun 2017. Jakarta, Indonesia: BNN RI.
Ramaekers, J. G., Kauert, G., Theunissen, E. L., Toennes, S. W., & Moeller, M. R. (2009). Neurocognitive Performance During Acute THC Intoxication in Heavy and Occasional Cannabis Users. Journal of Psychopharmacology, 23(3), 266-277.
Riedel, G., & Davies, S. N. (2005). Cannabinoid Function in Learning, Memory and Plasticity. In R. G. Pertwee, Cannabinoids (pp. 445-477). Belin, Germany: Springer-Verlag Berlin Heidelberg.
Ringen, P. A., Vaskinn, A., Sundet, K., Engh, J. A., Jónsdóttir, H., Simonsen, C., . . . Andreassen, O. A. (2010). Opposite Relationships Between Cannabis Use and Neurocognitive Functioning in Bipolar Disorder and Schizophrenia. Psychological Medicine, 40(8), 1337-1347.
Ross, J. M., Ellingson, J. M., Rhee, S. H., Hewitt, J. K., Corley, R. P., Lessem, J. M., & Friedman, N. P. (2020). Investigating the Causal Effect of Cannabis Use on Cognitive Function with a Quasi-Experimental Co-Twin Design. Drug and Alcohol Dependence, 206, 107712.
Sagar, K. A., & Gruber, S. A. (2018). Interactions Between Recreational Cannabis Use and Cognitive Function: Lesson from Functional Magentic Resonance Imaging. Annals of the New York Academy of Sciences, 1451(1), 42. doi:doi: 10.1111/nyas.13990
Saputro, W. T. (2018). Implementasi Kebijakan Pendayagunaan Tanaman Ganja di Indonesia Melalui UU Narkotika No. 35 Tahun 2009 (Undergraduate Thesis). Jawa Timur, Indonesia: Universitas Brawijaya. Retrieved from http://repository.ub.ac.id/163267/
Sawaguchi, T. (2001). The Effects of Dopamine and Its Antagonists on Directional Delay-Period Activity of Prefrontal Neurons in Monkeys During an Oculomotor Delayed-Response Task. Neuroscience Research, 41(2), 115-128.
Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F., Moore, T. M., & Gur, R. C. (2018). Association of Cannabis with Cognitive Functioning in Adolecent and Young Adults: A Systemic Review and Meta-Analysis. JAMA Psychiatry, 75(6), 585-595.
Scott, J. C., Wolf, D. H., Calkins, M. E., Bach, E. C., Weidner, J., Kosha, R., . . . Gur, R. C. (2017). Cognitive Functioning of Adolescent and Young Adult Cannabis Users in Philadelphia Neurodevelopmental Cohort. Psychology of Addictive Behaviors, 31(4), 423-434.
Sestieri, C., Corbetta, M., Romani, G. L., & Shulman, G. L. (2011). Episodic Memory Retrieval, Parietal Cortex, and the Default Mode Network: Functional and Topographic Analyses. Journal of Neuroscience, 31(12), 4407-4420. doi:doi: 10.1523/JNEUROSCI.3335-10.2011.
Singh, S., & Joshi, N. (2019). Preface. In S. Singh, & N. Joshi, Pathology, Prevention and Therapeutics of Neurodegenerative Disease (pp. v-vi). Singapore, Singapore: Springer Nature Singapore Pte Ltd.
Smith, E. E., & Kosslyn, S. M. (2014). Psikologi Kognitif: Pikiran dan Otak. (H. S. Prajitno, & S. M. Soetjipto, Trans.) Yogyakarta, Indonesia: Pustaka Pelajar.
Solowij, N., Broyd, S. J., Beale, C., Prick, J.-.. A., Greenwood, L.-.. M., van Hell, H., . . . Yücel, M. (2018). Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial. Cannabis and Cannabinoid Research, 3(1), 21-34.
Squire, L. R., Stark, C. E., & Clark, C. E. (2004). The Medial Temporal Lobe. Annual Review of Neuroscience, 27, 279-306.
Sujono, A. R., & Daniel, B. (2013). Komentar dan Pembahasan Undang-Undang Nomor 35 Tahun 2009 tentang Narkotika. Jakarta, Indonesia: Sinar Grafika.
(2009). Undang-undang Nomor 35 Tahun 2009 tentang Narkotika.
van Hell, H. H., Bossong, M. G., Jager, G., Kahn, R. S., & Ramsey, N. F. (2011). Methods of Pharmacological Imaging of the Cannabinoid System (PhICS) Study: Towards Understanding the Role of the Brain Endocannabinoid System in Human Cogntion. International Journal of Methods in Psychiatric Research, 20(1), 10-27.
van Hell, H. H., Jager, G., Bossong, M. G., Brouwer, A., Jansma, J. M., Zuurman, L., . . . Ramsey, N. F. (2012). Involvement of the Endocannabinoid System in Reward Processing in the Human Brain. Psychopharmacology, 219(4), 981-990.
Walkey, L. R., Tanguay, R. L., & el-Guebaly, N. (2018). Narrative Review of Cannabidiol as an Antipsychotic and Recommendations for Legal Regulations. Canadian Journal of Addiction, 9(3), 23-29.
Widodo, W., & Surjaningrum, E. R. (2014). Studi Perbandingan Kemampuan Working Memory pada Pecandu Ganja dan Non-Pecandu Ganja. Jurnal Psikologi Klinis dan Kesehatan Mental, 3(2), 72-78.
Wise, R. A., & Rompre, P. P. (1989). Brain Dopamine and Reward. Annual Review of Psychology, 40(1), 191-225.
Wright, N. E., Maple, K. E., & Lisdahl, K. M. (2017). Effects of Cannabis Use on Neurocognition in Adolescents and Emerging Adults. In V. R. Preedy, Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis, and Treatment (pp. 151-159). London, UK: Academic Press.
Yanes, J. A., Riedel, M. C., Ray, K. L., Kirkland, A. E., Bird, R. T., Boeving, E. R., . . . Sutherland, M. T. (2018). Neuroimaging Meta-Analysis of Cannabis Use Studies Reveals Convergent Functional Alterations in Brain Regions Supporting Cognitive Control and Reward Processing. Journal of Pharmacology, 32(3), 283-295.
Zanettini, C., Panlilio, L. V., Aliczki, M., Goldberg, S. R., Haller, J., & Yasar, S. (2011). Effects of Endocannabinoid System Modulation on Cognitive and Emotional Behavior. Frontiers in Behavioral Neuroscience, 5, 57.
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Buletin Psikologi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.